E-cadherin Expression is Regulated by MiR-192/215 by a Mechanism That is Independent of the Profibrotic Effects of Transforming Growth Factor-beta
Overview
Authors
Affiliations
Objective: Increased deposition of extracellular matrix (ECM) within the kidney is driven by profibrotic mediators including transforming growth factor-beta (TGF-beta) and connective tissue growth factor (CTGF). We investigated whether some of their effects may be mediated through changes in expression of certain microRNAs (miRNAs).
Research Design And Methods: Proximal tubular cells, primary rat mesangial cells, and human podocytes were analyzed for changes in the expression of key genes, ECM proteins, and miRNA after exposure to TGF-beta (1-10 ng/microl). Tubular cells were also infected with CTGF-adenovirus. Kidneys from diabetic apoE mice were also analyzed for changes in gene expression and miRNA levels.
Results: TGF-beta treatment was associated with morphologic and phenotypic changes typical of epithelial-mesenchymal transition (EMT) including increased fibrogenesis in all renal cell types and decreased E-cadherin expression in tubular cells. TGF-beta treatment also modulated the expression of certain miRNAs, including decreased expression of miR-192/215 in tubular cells, mesangial cells, which are also decreased in diabetic kidney. Ectopic expression of miR-192/215 increased E-cadherin levels via repressed translation of ZEB2 mRNA, in the presence and absence of TGF-beta, as demonstrated by a ZEB2 3'-untranslated region luciferase reporter assay. However, ectopic expression of miR-192/215 did not affect the expression of matrix proteins or their induction by TGF-beta. In contrast, CTGF increased miR-192/215 levels, causing a decrease in ZEB2, and consequently increased E-cadherin mRNA.
Conclusions: These data demonstrate the linking role of miRNA-192/215 and ZEB2 in TGF-beta/CTGF-mediated changes in E-cadherin expression. These changes appear to occur independently of augmentation of matrix protein synthesis, suggesting that a multistep EMT program is not necessary for fibrogenesis to occur.
MicroRNAs in diabetes mellitus.
Shaik Syed Ali P, Ahmad M, Parveen K J Diabetes Metab Disord. 2025; 24(1):77.
PMID: 40060270 PMC: 11885724. DOI: 10.1007/s40200-025-01591-y.
Alqabandi J, David R, Abdel-Motal U, ElAbd R, Youcef-Toumi K Sci Rep. 2024; 14(1):30107.
PMID: 39627312 PMC: 11615046. DOI: 10.1038/s41598-024-79154-z.
Understanding molecular mechanisms and miRNA-based targets in diabetes foot ulcers.
Anuradha U, Mehra N, Khatri D Mol Biol Rep. 2024; 51(1):82.
PMID: 38183502 DOI: 10.1007/s11033-023-09074-0.
SIRT6's function in controlling the metabolism of lipids and glucose in diabetic nephropathy.
Wang Y, Liu T, Cai Y, Liu W, Guo J Front Endocrinol (Lausanne). 2023; 14:1244705.
PMID: 37876546 PMC: 10591331. DOI: 10.3389/fendo.2023.1244705.
Barreiro K, Dwivedi O, Rannikko A, Holthofer H, Tuomi T, Groop P Genes (Basel). 2023; 14(7).
PMID: 37510317 PMC: 10379145. DOI: 10.3390/genes14071415.